FOSRENOL Chewable tablet Ref.[8721] Active ingredients: Lanthanum

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2022  Publisher: Takeda UK Ltd, 1 Kingdom Street, London, W2 6BD, United Kingdom

Product name and form

Fosrenol 500 mg chewable tablets.

Fosrenol 750 mg chewable tablets.

Fosrenol 1000 mg chewable tablets.

Pharmaceutical Form

Chewable tablet.

Fosrenol 500 mg chewable tablets: White, round, 18mm, bevelled-edge flat tablets debossed with ‘S405/500’ on one side.

Fosrenol 750 mg chewable tablets: White, round, 20mm, bevelled-edge flat tablets debossed with ‘S405/750’ on one side.

Fosrenol 1000 mg chewable tablets: White, round, 22mm, bevelled-edge flat tablets debossed with ‘S405/1000’ on one side.

Qualitative and quantitative composition

Fosrenol 500 mg chewable tablets: Each chewable tablet contains lanthanum carbonate hydrate corresponding to 500 mg lanthanum.

Fosrenol 750 mg chewable tablets: Each chewable tablet contains lanthanum carbonate hydrate corresponding to 750 mg lanthanum.

Fosrenol 1000 mg chewable tablets: Each chewable tablet contains lanthanum carbonate hydrate corresponding to 750 mg lanthanum.

Excipient(s) with known effect:

Fosrenol 500 mg chewable tablets: Chewable tablets also contain on average 1066 mg of dextrates, containing glucose.

Fosrenol 750 mg chewable tablets: Chewable tablets also contain on average 1599 mg of dextrates, containing glucose.

Fosrenol 1000 mg chewable tablets: Chewable tablets also contain on average 2132 mg of dextrates, containing glucose

For the full list of excipients, see section 6.1.

Active Ingredient Description
Lanthanum

Lanthanum is indicated as a phosphate binding agent for use in the control of hyperphosphataemia.

List of Excipients

Dextrates (hydrated)
Colloidal anhydrous silica
Magnesium stearate

Pack sizes and marketing

White cylindrical HDPE bottles containing a rayon coil fitted with a tamper evident, child resistant polypropylene screw cap.

Pack sizes:

Fosrenol 500 mg chewable tablets: 20, 45 tablets. Multipack containing 90 (2 packs of 45) chewable tablets.

Fosrenol 750 mg chewable tablets: 15, 45 tablets. Multipack containing 90 (6 packs of 15) chewable tablets.

Fosrenol 1000 mg chewable tablets: 10, 15 tablets. Multipack containing 90 (6 packs of 15) chewable tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Takeda UK Ltd, 1 Kingdom Street, London, W2 6BD, United Kingdom

Marketing authorization dates and numbers

Fosrenol 500 mg chewable tablets: PL 16189/0139
Fosrenol 750 mg chewable tablets: PL 16189/0140
Fosrenol 1000 mg chewable tablets: PL 16189/0138

Date of first authorisation: 12 September 2006
Date of latest renewal: 19 March 2014

Drugs

Drug Countries
FOSRENOL Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.